← Browse by Condition
Medical Condition

high risk large b cell lymphoma lbcl

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT05605899 Phase 3
Recruiting

Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma

Enrollment
300 pts
Location
United States, Austr...
Sponsor
Kite, A Gilead Company
View Trial →